0001567619-23-001851.txt : 20230203 0001567619-23-001851.hdr.sgml : 20230203 20230203171514 ACCESSION NUMBER: 0001567619-23-001851 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230201 FILED AS OF DATE: 20230203 DATE AS OF CHANGE: 20230203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tyagarajan N. V. CENTRAL INDEX KEY: 0001408239 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33626 FILM NUMBER: 23587273 MAIL ADDRESS: STREET 1: 825 EIGHTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Genpact LTD CENTRAL INDEX KEY: 0001398659 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 980533350 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 BUSINESS PHONE: 4412952244 MAIL ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 4 1 doc1.xml FORM 4 X0306 4 2023-02-01 0 0001398659 Genpact LTD G 0001408239 Tyagarajan N. V. C/O GENPACT LLC 521 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10175 1 1 0 0 President and CEO Common Shares 2023-02-01 4 M 0 50000 19.35 A 672518 D Common Shares 2023-02-01 4 S 0 50000 47.4188 D 622518 D Common Shares 2023-02-02 4 M 0 50000 19.35 A 672518 D Common Shares 2023-02-02 4 S 0 50000 47.6025 D 622518 D Common Shares 2023-02-03 4 M 0 50000 19.35 A 672518 D Common Shares 2023-02-03 4 S 0 50000 47.1048 D 622518 D Common Shares 10000 I By Trust Employee Stock Option (Right to Buy) 19.35 2023-02-01 4 M 0 50000 0 D 2023-05-30 Common Shares 50000 850000 D Employee Stock Option (Right to Buy) 19.35 2023-02-02 4 M 0 50000 0 D 2023-05-30 Common Shares 50000 800000 D Employee Stock Option (Right to Buy) 19.35 2023-02-03 4 M 0 50000 0 D 2023-05-30 Common Shares 50000 750000 D The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.02 to $47.80. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.21 to $47.92. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.83 to $47.47. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein. The option vested 50% on January 10, 2016 and the remainder on January 10, 2018. The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. /s/ Thomas D. Scholtes, as Attorney-in-fact for N.V. Tyagarajan 2023-02-03